Deep Track Capital, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001856083

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2024 · 69 positions · Total reported value $3.07B · Top-10 concentration 42.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 59.3% · 18 new · 15 cut · 15 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +27.7% · vs SPY +12.9% · Prev Value $6.12B — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2024 13F filing, Deep Track Capital, LP disclosed 69 equity positions with a combined reported value of $3.07B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 42.3% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2024 were ARGX ($197.86M), DVAX ($139.55M), GH ($137.65M). By sector, the heaviest allocations are Health Care 72.5%, Other 27.5%. Versus the prior quarter, allocation shifted toward Other (+5.8pp) and away from Health Care (-5.8pp).

Versus the prior quarter, Deep Track Capital, LP opened 18 new positions, trimmed 15 and fully exited 15, a turnover rate of 59.3% of positions. The portfolio's overlap with the prior quarter was 76% of names.

The largest new positions opened in Q3 2024 were MBX ($78.43M), ORKA ($30.27M), RNAM ($21.82M).

Of the 15 positions fully exited versus the prior quarter, the largest were AMGN ($179.66M), INSM ($134.00M), ALNY ($121.50M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2024)

  • MBX MBX BIOSCIENCES INC COM · $78.43M
  • ORKA ORUKA THERAPEUTICS INC · $30.27M
  • RNAM AVIDITY BIOSCIENCES INC · $21.82M
  • CNTA CENTESSA PHARMACEUTICALS PLC · $21.59M
  • BCAX BICARA THERAPEUTICS INC · $20.30M
  • AKRO AKERO THERAPEUTICS INC · $19.79M
  • XNCR XENCOR INC COM · $16.09M
  • HELP CYBIN INC · $13.60M

Fully Exited (vs previous quarter)

  • AMGN AMGEN INC · prev qtr: $179.66M
  • INSM INSMED INC · prev qtr: $134.00M
  • ALNY ALNYLAM PHARMACEUTICALS INC · prev qtr: $121.50M · history
  • HLVX HILLEVAX INC · prev qtr: $26.50M
  • PRAX PRAXIS PRECISION MEDICINES I · prev qtr: $16.11M
  • CYBN CYBIN INC · prev qtr: $15.76M
  • AGEN AGENUS INC · prev qtr: $5.25M
  • RPTX REPARE THERAPEUTICS INC · prev qtr: $2.98M

Insider Transactions (Form 4)

Latest Deep Track Capital, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-08-06 Conversion Attovia Therapeutics, Inc. 1,957,138 — SEC filing

All insider transactions →

Fund Profile

Deep Track Capital, LP is an SEC-registered 13F filer based in Greenwich, CT, United States. As of Q2 2026 it reported 66 US equity positions with a combined value of $6.72B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: GREENWICH, CT, United States
  • SEC registration: 801-120500 (status: Approved), registered 2021-03-12
  • Regulatory AUM (Form ADV): $8.37B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: deeptrackcapital.com

Portfolio Structure

  • 66 positions · $6.72B reported value (Q2 2026)
  • Top 10 holdings = 40.5% of reported value
  • Largest position: GH (GUARDANT HEALTH INC) at 7.6%
  • Average position size: $101.75M

Sector Tilt

  • Health Care 95.4%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q2 2026: 18 new, 20 added, 15 reduced, 15 exited
  • 13 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 72.5%
Other 27.5%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 365.00K $197.86M 6.45%
6.45%
Reduce
2 12.53M $139.55M 4.55%
4.55%
Add
3 6.00M $137.65M 4.49%
4.49%
Add
4 4.40M $126.91M 4.14%
4.14%
Add
5 4.35M $123.95M 4.04%
4.04%
Add
6 3.84M $123.16M 4.01%
4.01%
Add
7 3.28M $117.89M 3.84%
3.84%
Reduce
8 1.60M $117.12M 3.82%
3.82%
Add
9 12.72M $110.68M 3.61%
3.61%
Hold
10 4.95M $101.72M 3.31%
3.31%
Add
11 3.50M $97.97M 3.19%
3.19%
Hold
12 3.18M $91.49M 2.98%
2.98%
Reduce
13 2.20M $88.13M 2.87%
2.87%
Add
14 3.87M $86.92M 2.83%
2.83%
Reduce
15 3.75M $85.33M 2.78%
2.78%
Reduce
16 3.55M $80.29M 2.62%
2.62%
Add
17 3.02M $78.43M 2.56%
2.56%
New
18 5.97M $66.95M 2.18%
2.18%
Hold
19 1.00M $58.74M 1.92%
1.92%
Hold
20 15.27M $55.44M 1.81%
1.81%
Hold
21 1.22M $53.57M 1.75%
1.75%
Add
22 4.00M $47.76M 1.56%
1.56%
Hold
23 5.58M $46.51M 1.52%
1.52%
Reduce
24 4.10M $44.28M 1.44%
1.44%
Add
25 3.58M $41.23M 1.34%
1.34%
Reduce
26 1.73M $40.35M 1.31%
1.31%
Reduce
27 7.07M $40.20M 1.31%
1.31%
Add
28 1.96M $38.37M 1.25%
1.25%
Add
29 7.58M $34.39M 1.12%
1.12%
Reduce
30 629.91K $33.26M 1.08%
1.08%
Add
31 1.24M $30.27M 0.99%
0.99%
New
32 504.83K $30.12M 0.98%
0.98%
Add
33 1.00M $29.41M 0.96%
0.96%
Reduce
34 1.10M $29.37M 0.96%
0.96%
Add
35 600.33K $28.41M 0.93%
0.93%
Reduce
36 850.00K $28.41M 0.93%
0.93%
Add
37 475.00K $21.82M 0.71%
0.71%
New
38 1.35M $21.59M 0.70%
0.70%
New
39 4.63M $21.59M 0.70%
0.70%
Hold
40 15.92M $20.70M 0.68%
0.68%
Reduce
41 2.77M $20.47M 0.67%
0.67%
Add
42 796.85K $20.30M 0.66%
0.66%
New
43 689.78K $19.79M 0.65%
0.65%
New
44 5.57M $19.50M 0.64%
0.64%
Hold
45 1.00M $18.18M 0.59%
0.59%
Reduce
46 200.00K $17.97M 0.59%
0.59%
Reduce
47 2.61M $17.21M 0.56%
0.56%
Add
48 4.90M $16.71M 0.55%
0.55%
Reduce
49 800.00K $16.09M 0.52%
0.52%
New
50 4.18M $15.36M 0.50%
0.50%
Hold

FAQ

What did Deep Track Capital, LP buy in 2024-Q3?

In its 2024-Q3 13F filing, Deep Track Capital, LP reported 69 equity positions worth $3.07B in aggregate; its largest disclosed positions were ARGX ($197.86M), DVAX ($139.55M), GH ($137.65M).

How large is Deep Track Capital, LP's portfolio?

Deep Track Capital, LP reported $3.07B of long equity holdings across 69 positions as of 2024-Q3. Top-10 holdings account for 42.3% of reported value.

What is Deep Track Capital, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/deep-track-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →